Showing results (2911-2920 of 6,794) with videos related to
Sort By:
Pageof 680
Clinical Therapeutics|March 5, 2013
Impact of local administration of liposome bupivacaine for postsurgical analgesia on wound healing: a review of data from ten prospective, controlled clinical studiesRichard Baxter, Kenneth Bramlett, Erol Onel, et al.Clinical Therapeutics|April 17, 2013
Descriptive comparison of drug treatment-persistent, -nonpersistent, and nondrug treatment patients with newly diagnosed attention deficit/hyperactivity disorder in GermanySebastian Braun, Leo Russo, Jan Zeidler, et al.Clinical Therapeutics|March 8, 2013
Clinical and economic evaluation of an evidence-based institutional epoetin-utilization management programMitchell S Buckley, Sandra L Kane-Gill, Shardool A PatelClinical Therapeutics|February 16, 2013
Oral bioavailability of rifampicin, isoniazid, ethambutol, and pyrazinamide in a 4-drug fixed-dose combination compared with the separate formulations in healthy Chinese male volunteersJian Xu, Haixia Jin, Hui Zhu, et al.Clinical Therapeutics|July 20, 2014
Clinical significance of peripheral blood lymphocyte sensitivity to glucocorticoids for the differentiation of high-risk patients with decreased allograft function after glucocorticoid withdrawal in renal transplantationGulimire Muhetaer, Hironori Takeuchi, Sakae Unezaki, et al.Clinical Therapeutics|July 23, 2014
Effect of ketoconazole on lobeglitazone pharmacokinetics in Korean volunteersEun Sil Oh, Choon Ok Kim, Ki Hyon Kim, et al.Clinical Therapeutics|July 27, 2014
Efficacy and safety of weight-based insulin glargine dose titration regimen compared with glucose level- and current dose-based regimens in hospitalized patients with type 2 diabetes: a randomized, controlled studyXiaowei Li, Tao Du, Wangen Li, et al.Clinical Therapeutics|July 28, 2014
Effects of empiric antifungal therapy for septic shock on time to appropriate therapy for Candida infection: a pilot studyScott T Micek, Heather Arnold, Paul Juang, et al.Clinical Therapeutics|July 30, 2014
Evaluation of the pharmacokinetic interaction between ticagrelor and venlafaxine, a cytochrome P-450 2D6 substrate, in healthy subjectsRenli Teng, Mirjana Kujacic, Judith HsiaClinical Therapeutics|July 31, 2014
Application site affects the pharmacokinetics of topical testosterone applied to the axilla compared with the inner armSusan R Davis, Allan M Evans, Andrew HumberstonePageof 680